Argus analyst Jasper Hellweg raised his price target on HCA Healthcare to $114 and kept his Buy rating after Q4 earnings, pointing to the company's strong guidance, positive impact of U.S. tax changes, and expanding business. The analyst also initiates a FY19 EPS view of $9.26, which implies a 8.4% increase from his expected FY18 forecast in addition to his modeled 11% rise in FY19 revenue. Hellweg adds that the company has been able to respond to greater competition in the commercial market and a less favorable payer mix with acquisitions and the strategic use of big data.

Catheter Precision (VTAK) has received its first purchase order for LockeT from an HCA Healthcare (HCA) facility.

Augmedix (AUGX) announced the general availability of Augmedix Go for emergency departments, marking the launch of the industry's first fully-automated, generative AI powered medical documentation product for EDs across the country. The launch incorporates learnings from a pilot program with HCA Healthcare (HCA), one of the nation's leading healthcare providers. As part of the pilot, ED physicians in four HCA Healthcare hospitals utilized Augmedix Go to automate medical documentation, with the product instantaneously drafting their medical notes from patient visits. "The launch of Augmedix Go in the ED represents our unwavering commitment to develop solutions for health systems that improve their workflows. Our agility and flexible architecture, exhibited by our broad product suite and open network platform, help us address the complex and varying needs of clinicians and providers," said Manny Krakaris, CEO of Augmedix. "We have built a sophisticated platform designed to enable clinicians to be present with their patients while trusting that Augmedix technology is doing administrative work unobtrusively in the background."